Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brian D Kent

Showing results (41-50 of 74) with videos related to

Pageof 8
Sort By:
Journal of Clinical Sleep Medicine : JCSM : Official Publication of the American Academy of Sleep Medicine|August 7, 2019
Nondipping Nocturnal Blood Pressure Predicts Sleep Apnea in Patients With HypertensionSophie J Crinion, Silke Ryan, Jana Kleinerova, et al.
ERJ Open Research|February 4, 2020
Inflammatory and microbiological associations with near-fatal asthma requiring extracorporeal membrane oxygenationSunil Patel, Neeraj M Shah, Akanksha M Malhotra, et al.
Pediatric Pulmonology|January 15, 2014
Asthma and cystic fibrosis: a tangled webBrian D Kent, Stephen J Lane, Edwin J van Beek, et al.
Sleep Medicine|March 21, 2020
Adherence to wakefulness promoting medication in patients with narcolepsyLaura Pérez-Carbonell, Elaine Lyons, Valentina Gnoni, et al.
ERJ Open Research|January 28, 2020
Oral corticosteroid-sparing effects of reslizumab in the treatment of eosinophilic granulomatosis with polyangiitisBrian D Kent, Grainne d'Ancona, Mariana Fernandes, et al.
The European Respiratory Journal|February 16, 2020
Adherence to corticosteroids and clinical outcomes in mepolizumab therapy for severe asthmaGráinne d'Ancona, Joanne Kavanagh, Cris Roxas, et al.
Lancet (London, England)|December 10, 2023
Reduction of daily maintenance inhaled corticosteroids in patients with severe eosinophilic asthma treated with benralizumab (SHAMAL): a randomised, multicentre, open-label, phase 4 studyDavid J Jackson, Liam G Heaney, Marc Humbert, et al.
Immunotherapy|January 9, 2025
Plain language summary of the SHAMAL study in patients with severe eosinophilic asthma treated with benralizumabDavid J Jackson, Liam G Heaney, Marc Humbert, et al.
Journal of Sleep Research|October 20, 2017
Effectiveness and side-effect profile of stimulant therapy as monotherapy and in combination in the central hypersomnias in clinical practiceChiraag Thakrar, Kishankumar Patel, Grainne D'ancona, et al.
Chest|April 11, 2020
Real-World Effectiveness and the Characteristics of a "Super-Responder" to Mepolizumab in Severe Eosinophilic AsthmaJoanne E Kavanagh, Grainne d'Ancona, Maria Elstad, et al.
Pageof 8

Showing results (41-50 of 74) with videos related to

Sort By:
Pageof 8
Journal of Clinical Sleep Medicine : JCSM : Official Publication of the American Academy of Sleep Medicine|August 7, 2019
Nondipping Nocturnal Blood Pressure Predicts Sleep Apnea in Patients With HypertensionSophie J Crinion, Silke Ryan, Jana Kleinerova, et al.
ERJ Open Research|February 4, 2020
Inflammatory and microbiological associations with near-fatal asthma requiring extracorporeal membrane oxygenationSunil Patel, Neeraj M Shah, Akanksha M Malhotra, et al.
Pediatric Pulmonology|January 15, 2014
Asthma and cystic fibrosis: a tangled webBrian D Kent, Stephen J Lane, Edwin J van Beek, et al.
Sleep Medicine|March 21, 2020
Adherence to wakefulness promoting medication in patients with narcolepsyLaura Pérez-Carbonell, Elaine Lyons, Valentina Gnoni, et al.
ERJ Open Research|January 28, 2020
Oral corticosteroid-sparing effects of reslizumab in the treatment of eosinophilic granulomatosis with polyangiitisBrian D Kent, Grainne d'Ancona, Mariana Fernandes, et al.
The European Respiratory Journal|February 16, 2020
Adherence to corticosteroids and clinical outcomes in mepolizumab therapy for severe asthmaGráinne d'Ancona, Joanne Kavanagh, Cris Roxas, et al.
Lancet (London, England)|December 10, 2023
Reduction of daily maintenance inhaled corticosteroids in patients with severe eosinophilic asthma treated with benralizumab (SHAMAL): a randomised, multicentre, open-label, phase 4 studyDavid J Jackson, Liam G Heaney, Marc Humbert, et al.
Immunotherapy|January 9, 2025
Plain language summary of the SHAMAL study in patients with severe eosinophilic asthma treated with benralizumabDavid J Jackson, Liam G Heaney, Marc Humbert, et al.
Journal of Sleep Research|October 20, 2017
Effectiveness and side-effect profile of stimulant therapy as monotherapy and in combination in the central hypersomnias in clinical practiceChiraag Thakrar, Kishankumar Patel, Grainne D'ancona, et al.
Chest|April 11, 2020
Real-World Effectiveness and the Characteristics of a "Super-Responder" to Mepolizumab in Severe Eosinophilic AsthmaJoanne E Kavanagh, Grainne d'Ancona, Maria Elstad, et al.
Pageof 8